GSA Capital Partners LLP Takes $1.91 Million Position in AirSculpt Technologies, Inc. $AIRS

Key Points

• GSA Capital Partners acquired 425,186 AirSculpt Technologies shares worth approximately $1.91 million, representing about 0.60% of the company. Institutional investors and hedge funds collectively own 91.54% of AIRS.
• AirSculpt reported quarterly revenue of $42.9 million and earnings of $0.01 per share, both slightly below analyst expectations. The company posted a negative net margin of 7.79% and negative return on equity of 5.83%.
• AIRS opened at $3.43, below its 50-day moving average of $4.53, while analysts have a consensus “Reduce” rating and a $4.50 price target.

GSA Capital Partners LLP acquired a new position in shares of AirSculpt Technologies, Inc. (NASDAQ:AIRS - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 425,186 shares of the company's stock, valued at approximately $1,913,000. GSA Capital Partners LLP owned about 0.60% of AirSculpt Technologies at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. BNP Paribas Financial Markets grew its position in shares of AirSculpt Technologies by 239.5% during the 3rd quarter. BNP Paribas Financial Markets now owns 5,952 shares of the company's stock valued at $48,000 after buying an additional 4,199 shares during the last quarter. Wells Fargo & Company MN grew its holdings in shares of AirSculpt Technologies by 49.9% during the fourth quarter. Wells Fargo & Company MN now owns 19,275 shares of the company's stock valued at $38,000 after purchasing an additional 6,420 shares during the last quarter. Aigen Investment Management LP acquired a new stake in shares of AirSculpt Technologies during the 4th quarter worth approximately $36,000. Millennium Management LLC bought a new stake in shares of AirSculpt Technologies in the 4th quarter worth approximately $33,000. Finally, Virtu Financial LLC acquired a new position in AirSculpt Technologies during the 4th quarter valued at approximately $30,000. 91.54% of the stock is owned by institutional investors and hedge funds.

AirSculpt Technologies Stock Performance

AIRS stock opened at $3.43 on Monday. The company has a 50-day simple moving average of $4.53 and a 200 day simple moving average of $3.57. The company has a market capitalization of $247.30 million, a P/E ratio of -19.05 and a beta of 2.33. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.32. AirSculpt Technologies, Inc. has a fifty-two week low of $1.51 and a fifty-two week high of $12.00.

AirSculpt Technologies (NASDAQ:AIRS - Get Free Report) last issued its quarterly earnings results on Monday, August 10th. The company reported $0.01 earnings per share for the quarter, missing analysts' consensus estimates of $0.02 by ($0.01). AirSculpt Technologies had a negative return on equity of 5.83% and a negative net margin of 7.79%.The company had revenue of $42.90 million during the quarter, compared to analyst estimates of $44.14 million.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the company. Leerink Partners set a $4.50 target price on AirSculpt Technologies in a research note on Thursday, May 14th. Wall Street Zen cut shares of AirSculpt Technologies from a "buy" rating to a "hold" rating in a research report on Saturday. Finally, Weiss Ratings raised AirSculpt Technologies from a "sell (e+)" rating to a "sell (d-)" rating in a report on Wednesday, July 1st. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Reduce" and a consensus price target of $4.50.

AirSculpt Technologies Profile

AirSculpt Technologies, Inc NASDAQ: AIRS is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.

Want to see what other hedge funds are holding AIRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AirSculpt Technologies, Inc. (NASDAQ:AIRS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source